Eltrocib-25 Tablet 7's

Eltrocib-25 Tablet 7's is used in the treatment of low platelet count (thrombocytopenia) in various blood-related disorders. The detailed uses of Eltrocib-25 Tablet 7's are as follows:

• Chronic immune thrombocytopenia (ITP): Eltrocib-25 Tablet 7's helps raise platelet counts in patients with chronic ITP to reduce the risk of bleeding when other treatments have failed.
• Severe aplastic anemia: Eltrocib-25 Tablet 7's helps the bone marrow produce more blood cells, including platelets, in patients whose condition has not responded to other therapies.
• Hepatitis C-associated low platelets: Historically, Eltrocib-25 Tablet 7's was used to increase platelet counts so some patients with chronic hepatitis C could receive interferon-based treatment. Today, newer antiviral medicines are more commonly used, and your doctor will decide whether Eltrocib-25 Tablet 7's is appropriate for your treatment plan. 

• Helps reduce bleeding: Raises platelet counts to lower the risk of bruising and bleeding.
• Supports important treatments: Helps patients receive necessary medical procedures or other treatments safely.
• May reduce transfusions: Helps decrease the need for frequent platelet transfusions in some patients

• Eltrocib-25 Tablet 7's can be taken on an empty stomach, at least 1 hour before or 2 hours after eating.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Eltrocib-25 Tablet 7's as a whole with a glass of water.
• Do not crush, break, or chew it.

• Watch your calcium intake timing: Avoid eating calcium-rich foods like yogurt, cheese, milk, or calcium-fortified juices close to your dosing time. Maintain a strict window of 4 hours before or 2 hours after taking the medicine.
• Avoid certain supplements: Do not take multivitamins, antacids, or supplements containing iron, calcium, magnesium, aluminum, selenium, or zinc within the restricted window, as they bind to the medication and stop its absorption.
• Keep up with regular blood tests: Attend all scheduled blood tests. Your doctor will usually check your platelet count and liver function before starting treatment and regularly during therapy, often every month or as needed, to make sure the medicine is working safely.
• Prevent injuries: Because your platelet levels are still being managed, take precautions to avoid cuts, falls, or bruising. Use a soft-bristled toothbrush and a safety razor to lower the risk of bleeding.

• Inspect the medicine before use: Always check that you have the correct strength of Eltrocib-25 Tablet 7's before taking your dose.
• Do not stop treatment abruptly: Do not stop taking Eltrocib-25 Tablet 7's suddenly, as your platelet count may fall rapidly and increase the risk of serious bleeding. Your doctor will advise you if treatment should be stopped and will usually monitor your platelet counts for about 4 weeks after discontinuation.
• Report vision changes promptly: Contact your doctor immediately if you notice blurred vision or any other changes in your eyesight, as Eltrocib-25 Tablet 7's may increase the risk of cataracts.
• Inform healthcare providers before procedures: Tell your doctor, dentist, or surgeon that you are taking Eltrocib-25 Tablet 7's before undergoing any medical, surgical, or dental procedure.